Effects of Empagliflozin on Urine Biomarkers in EMPA-KIDNEY
Greco Mark Malijan(University of Oxford), William G. Herrington(Oxford Health NHS Foundation Trust), Killian Donovan(National Health Service), Stewart Moffat(University of Oxford), Natalie Staplin(University of Oxford), David Z.I. Cherney(University Health Network), Colin Baigent(University of Oxford), Olivier Devuyst(Cliniques Universitaires Saint-Luc), Katherine R. Tuttle(Providence Regional Medical Center Everett), Nadine Nägele(University of Zurich), Dilushi Wijayaratne(The Royal Free Hospital), Dominik Steubl(Boehringer Ingelheim (Germany)), Doreen Zhu, Daniel S. Chapman(University of Stirling), Martin Landray(Gentofte Hospital), Roberto Pontremoli(Ospedale Policlinico San Martino), Sibylle J. Hauske(Heidelberg University), Richard Haynes, Christoph Wanner(University of Würzburg), Michael Hill(University of Oxford), Sarah Y A Ng, Michael G. Shlipak(San Francisco VA Medical Center), Joachim H Ix(University of San Diego), Michaela Petrini(University of Oxford), Rebecca J. Sardell(University of Miami), Parminder K. Judge(University of Oxford)
Cited by 8
Related Papers
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
|JAMA|2020|2.4k
Interpretation of the evidence for the efficacy and safety of statin therapy
|The Lancet|2016|1.8k